Splanchnic nerve stimulation for treatment of obesity

Details for Australian Patent Application No. 2004216247 (hide)

Owner Leptos Biomedical, Inc.

Inventors Dobak, John D. Iii

Agent Davies Collison Cave

Pub. Number AU-B-2004216247

PCT Pub. Number WO2004/075974

Priority 60/479,933 19.06.03 US; 60/452,361 05.03.03 US; 60/466,805 30.04.03 US; 60/450,534 25.02.03 US; 60/496,437 20.08.03 US; 60/466,890 30.04.03 US

Filing date 24 February 2004

Wipo publication date 10 September 2004

Acceptance publication date 28 January 2010

International Classifications

A61N 1/18 (2006.01) Electrotherapy - Applying electric currents by contact electrodes

A61N 1/00 (2006.01) Electrotherapy

A61N 1/05 (2006.01) Electrotherapy - for implantation or insertion into the body, e.g. heart electrode

A61N 1/36 (2006.01) Electrotherapy - for stimulation, e.g. heart pace-makers

Event Publications

29 September 2005 PCT application entered the National Phase

  PCT publication WO2004/075974 Priority application(s): WO2004/075974

28 January 2010 Application Accepted

  Published as AU-B-2004216247

13 May 2010 Corrigenda

  Applications Accepted - Name Index Under the name Leptos Biomedical, Inc., Application No. 2004216247, under INID (72) correct the inventor to read Dobak III, John D.

27 May 2010 Standard Patent Sealed

29 July 2010 Assignment Registered

  Leptos Biomedical, Inc. The patent has been assigned to Advanced Neuromodulation Systems, Inc. d/b/a St. Jude Medical Neuromodulation Divison

26 August 2010 Corrigenda

  Assignments Registered Under the name Leptos Biomedical, Inc., Application No. 2004216247, under INID (71), correct the applicant name to Advanced Neuromodulation Systems, Inc. d/b/a St. Jude Medical Neuromodulation Division

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004216251-Use of intraputaminal infused glial cellline derived neurotrophic factor in the treatment of Parkinson's disease in humans

2004216246-Stabilized HBc chimer particles as therapeutic vaccine for chronic hepatitis